serum sickness-like reaction
Summary
Serum sickness-like reaction (SSLR) is a type III hypersensitivity-like reaction occurring days after exposure to certain drugs (classically cefaclor, amoxicillin, or other antibiotics), presenting with fever, urticarial/serpiginous rash, and arthralgias/arthritis. Unlike true serum sickness, it does not involve immune complex deposition with hypocomplementemia or vasculitis, and lacks renal involvement. It is self-limited and resolves with discontinuation of the offending drug.
Detail
Serum sickness-like reaction is a drug hypersensitivity reaction most commonly seen in children, classically triggered by cefaclor (a second-generation cephalosporin), but also reported with other beta-lactams, sulfonamides, bupropion, and rituximab/other biologics. It typically develops 1-3 weeks after initial drug exposure (or within 1-3 days on re-exposure) and presents with a triad of fever, urticarial or morbilliform rash (often with serpiginous/annular borders, sometimes with acral edema), and arthralgias or arthritis, sometimes with lymphadenopathy.
Pathophysiology: Unlike classic serum sickness (a true type III hypersensitivity reaction caused by circulating immune complexes depositing in vessel walls, activating complement, and causing vasculitis - historically seen after heterologous antiserum/antivenin administration), SSLR does not involve immune complex deposition, complement consumption, or vasculitis. The exact mechanism is debated but may involve reactive drug metabolites (e.g., in cefaclor, abnormal metabolism to a reactive metabolite in susceptible individuals) triggering an immune response, though this remains incompletely understood. Complement levels remain normal, distinguishing it from true serum sickness.
Clinical significance: SSLR is important to distinguish from more serious conditions in the differential, including true serum sickness, urticarial vasculitis, Stevens-Johnson syndrome, Kawasaki disease, and other drug reactions. Key distinguishing features include normal complement levels and absence of true vasculitis on biopsy (if performed), as well as the characteristic rash morphology and lack of renal/pulmonary involvement.
Management: Discontinue the offending drug. Symptoms are treated supportively with antihistamines, NSAIDs for arthralgias, and sometimes a short course of corticosteroids for severe cases. The condition is self-limited, typically resolving within 1-2 weeks after drug withdrawal. Patients should avoid re-exposure to the causative agent or cross-reactive drugs.
Sources
- First Aid for the USMLE Step 1
- Harrison's Principles of Internal Medicine
- UpToDate: Serum sickness and serum sickness-like reactions
- Kliegman, Nelson Textbook of Pediatrics
Reviewed by Medusa editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.